UCLA researchers say a drug candidate, DDL-920, reproduced key effects of physical stroke rehabilitation in mice, restoring movement control and brain connections involved in recovery. The findings, published in Nature Communications, suggest a possible drug target for stroke rehabilitation, though safety and human-trial testing are still needed. [stemcell.ucla.edu]
Continue reading...
Continue reading...